Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Ben G L, Vanneste"'
Autor:
Anshu Ankolekar, Ben G. L. Vanneste, Esther Bloemen-van Gurp, Joep G. van Roermund, Evert J. van Limbergen, Kees van de Beek, Tom Marcelissen, Victor Zambon, Matthias Oelke, Andre Dekker, Cheryl Roumen, Philippe Lambin, Adriana Berlanga, Rianne Fijten
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Patient decision aids (PDAs) can support the treatment decision making process and empower patients to take a proactive role in their treatment pathway while using a shared decision-making (SDM) approach making participatory medic
Externí odkaz:
https://doaj.org/article/8ba4766ec8e54e03a9ec4ea0f38e3d39
Autor:
Zhengfei Zhu, Jianjiao Ni, Xuwei Cai, Shengfa Su, Hongqing Zhuang, Zhenzhou Yang, Ming Chen, Shenglin Ma, Conghua Xie, Yaping Xu, Jiancheng Li, Hong Ge, Anwen Liu, Lujun Zhao, Chuangzhou Rao, Congying Xie, Nan Bi, Zhouguang Hui, Guangying Zhu, Zhiyong Yuan, Jun Wang, Lina Zhao, Wei Zhou, Chai Hong Rim, Arturo Navarro-Martin, Ben G. L. Vanneste, Dirk De Ruysscher, J. Isabelle Choi, Jacek Jassem, Joe Y. Chang, Lucyna Kepka, Lukas Käsmann, Michael T. Milano, Paul Van Houtte, Rafal Suwinski, Alberto Traverso, Hiroshi Doi, Yang-Gun Suh, Georges Noël, Natsuo Tomita, Roman O. Kowalchuk, Terence T. Sio, Baosheng Li, Bing Lu, Xiaolong Fu
Publikováno v:
Translational Lung Cancer Research, 11, 1763-1795. AME Publishing Company
Background: Lung cancer is the leading cause of cancer-related death worldwide, with non-small cell lung cancer (NSCLC) accounting for most cases. While radiotherapy has historically served as a palliative modality in metastatic NSCLC, considerable a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::140c02741b295d0cba9538b041139571
https://doi.org/10.21037/tlcr-22-644
https://doi.org/10.21037/tlcr-22-644
Publikováno v:
Transl Lung Cancer Res
Several studies have established that radiotherapy (RT) in combination with immunotherapy (IO) has a strong synergistic effect. RT changes the tumor microenvironment, generates local inflammation reactions, and enhances immunostimulatory effects, whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba67451385532e4e09038bb639328a3a
https://doi.org/10.21037/tlcr-20-304
https://doi.org/10.21037/tlcr-20-304
Autor:
Ludy C.H.W. Lutgens, Ben G. L. Vanneste, K. Reynders, Evert J. Van Limbergen, Jarno Melenhorst, Joep G. H. van Roermund, Tom Marcelissen
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 27, Iss, Pp 121-125 (2021)
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, 27, 121-125. Elsevier Ireland Ltd
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, 27, 121-125. Elsevier Ireland Ltd
Highlights • Radiotherapy in patients with inflammatory bowel disease remains controversial. • A biodegradable balloon is inserted between the prostate and the rectal wall. • The balloon pushes the anterior rectal wall outside of the high-dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b790da2dc993d0072e112b8608939f8
https://doi.org/10.1016/j.ctro.2021.01.007
https://doi.org/10.1016/j.ctro.2021.01.007
Autor:
Eline H. Huele, Maureen J.B. Aarts, Jacqueline M. Tromp, Michael Schaapveld, Ronald de Wit, Hetty A van den Berg, J. Alfred Witjes, Jourik A. Gietema, Tineke J. Smilde, Harmke J. Groot, Ben G. L. Vanneste, Gerard Groenewegen, J.L.H. Ruud Bosch, Janine Nuver, Simon Horenblas, Richard P. Meijer, Peter De Brouwer, Joost M. Blok
Publikováno v:
Journal of Clinical Oncology, 39, 4, pp. 319-327
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(4), 319-327. American Society of Clinical Oncology
Journal of clinical oncology, 39(4), 319-327. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(4):JCO2002352, 319-330. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 39(4), 319-+. American Society of Clinical Oncology
Journal of Clinical Oncology, 39, 319-327
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(4), 319-327. American Society of Clinical Oncology
Journal of clinical oncology, 39(4), 319-327. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(4):JCO2002352, 319-330. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 39(4), 319-+. American Society of Clinical Oncology
Journal of Clinical Oncology, 39, 319-327
PURPOSE Patients with testicular germ cell tumor (TGCT) are at increased risk of developing a contralateral TGCT (CTGCT). Although some studies suggest that prior treatment with platinum-based chemotherapy affects CTGCT risk, a relationship between C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b8ebb66bfc0bf529fbb59cef724a414
https://research.rug.nl/en/publications/b3478bd9-4547-4041-92f5-dfa0d616e655
https://research.rug.nl/en/publications/b3478bd9-4547-4041-92f5-dfa0d616e655
Autor:
Ruud Houben, Jarno Melenhorst, Murillo Bellezzo, Heike I. Grabsch, Rodrigo Oliva Perez, Frank Verhaegen, Nathalie Guedj, Angelita Habr-Gama, Danny Goudkade, Krzysztof Bujko, Evert J. Van Limbergen, Maaike Berbee, Ben G. L. Vanneste, Gabriel P. Fonseca, Jeroen Buijsen, An-Sofie Verrijssen, Jose G. Guillem
Publikováno v:
Radiother Oncol
Objective: In selected rectal cancer patients with residual local disease following neoadjuvant chemoradiation (CRT) and the preference of an organ preservation pathway, additional treatment with dose escalation by endoluminal radiotherapy (RT) may u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2091063c2d82851c880a83a4674faaa0
https://doi.org/10.1016/j.radonc.2019.10.003
https://doi.org/10.1016/j.radonc.2019.10.003
Autor:
Jian Hu, Zhaohui Fan, Qi-Xun Chen, Yi Zhang, Qingchen Wu, Satoshi Watanabe, Yang Liu, Jiaqing Xiang, Hecheng Li, Junqiang Fan, Hao Zhang, Junji Uchino, Wen-Xiang Wang, Xiao-Jie Pan, Haitao Ma, Hui Tian, Ben G. L. Vanneste, Nai-Quan Mao, Toyoaki Hida, Yun-Chao Huang, Takeo Nakada, Bin Qiu, Dirk De Ruysscher, Qiang Li, Kaican Cai, Hao Long, Qingquan Luo, Jie Jiang, Hongxu Liu, Wei-Dong Hu, Stefano Bongiolatti, Shinji Sasada, Tao Jiang, Chun Chen, Raffaele Califano, Fengwei Tan, Jie He, Peng Zhang, Lunxu Liu, Jun Chen, Nobuhiko Seki, Kenneth W. Merrell, Jun-Feng Liu, Zhenfa Zhang, Federico Cappuzzo, Sai Yendamuri, Pierfilippo Crucitti, Haruhiko Sugimura, Paul Hofman, Nan Wu, Gening Jiang, Yongde Liao, Chao Cheng, Shugeng Gao, Julian R. Molina, Li Wei, Lijie Tan, Giulio Metro, In-Jae Oh, Yusuke Tomita, Wenjie Jiao, Yuming Zhu, William C. Cho, Stefania Rizzo, Lanjun Zhang, Mariano Provencio, Sang-Won Um, Jessica C. Sieren, Ke-Neng Chen, Said Dermime, Dong Wang, Shidong Xu, Lin Yang, Kunshou Zhu, Tian-Yang Dai, Kye Young Lee, Filippo Longo, Muhammad Furqan
Publikováno v:
Transl Lung Cancer Res
Translational Lung Cancer Research, 10(9), 3713-3736. AME Publishing Company
Translational Lung Cancer Research, 10(9), 3713-3736. AME Publishing Company
The treatment of lung cancer is one of the major challenges in the field of oncology. According to statistics from the National Cancer Center of China in 2015, lung cancer has the highest incidence and mortality, with 733,300 new cases and 610,200 de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07c0c2fd811a6677077a5b6c9bd07ad9
https://pubmed.ncbi.nlm.nih.gov/35070744
https://pubmed.ncbi.nlm.nih.gov/35070744
Autor:
A. Webb, David Azria, Sarah L. Kerns, Karen Foweraker, Ana Carballo, Barbara Avuzzi, Luis Aznar-Garcia, Roxana Draghici, Monica Ramos, Stéphanie Peeters, Benjamin Gauter-Fleckenstein, Daniel S. Higginson, Anna Maria Paganoni, Ulrich Giesche, Monika Kaushik, Corinne Faivre-Finn, Ananya Choudhury, Andrea Manzoni, Jörg Schäfer, Carsten Herskind, Frances Kenny, Paolo Zunino, Valérie Fonteyne, Abigail Pascoe, S. Morlino, Paloma Sosa-Fajardo, Manjusha Keni, Karin Haustermans, A. Giraldo, Jaroslaw Krupa, Claudia Sangalli, Thomas Schnabel, Gert De Meerleer, Yolande Lievens, Patricia Calvo-Crespo, Marie-Pierre Farcy-Jacquet, Petra Seibold, Nicola Rares Franco, Ramón Lobato-Busto, Irene Fajardo-Paneque, Tim Rattay, Ana Vega, Riccardo Valdagni, Elena Delmastro, Irmgard Helmbold, Ben G. L. Vanneste, Richard G. Stock, Donna Appleton, Debbie Payne, Barry S. Rosenstein, Liv Veldeman, Rebecca Elliott, Tiziana Rancati, Alison M. Dunning, Claire P. Esler, Sridhar Thiagarajan, Elisabetta Garibaldi, Muriel Brengues, Michela Carlotta Massi, Simon Pilgrim, Maria C. De Santis, Wilfried De Neve, Miguel E. Aguado-Barrera, Evert J. Van Limbergen, Olivia-Fuentes-Rios, Paul Symonds, Jenny Chang-Claude, Elena Sperk, Catharine M L West, Petra Stegmaier, Antonio Gómez-Caamaño, Marzia Franceschini, Laura Torrado Moya, Simon Wright, Kufre Sampson, Kalliope Valassiadou, Francesca Ieva, Burkhard Neu, Isabel Dominguez-Rios, Francoise Bons, Marie-Luise Sautter-Bihl, Gilles Defraene, Tommaso Giandini, Meritxel Molla, Sheryl Green, Victoria Harrop, Alessandro Cicchetti, Christian Weiß, Caroline Weltens, Gabriele Pietro, Christopher Kent, Michael Ehmann, Paula Peleteiro, Dirk De Ruysscher, Thomas Blaschke, Ion Bioangiu, Hazem Khout, Samuel Lavers, Ahmed Osman, Laura Fachal, Subramaniam Vasanthan, Marc van Eijkeren, Laura Lozza, Céline Bourgier, Kelly Lambert, Johannes Claßen, Piet Ost, Kerstie Johnson, Christian Weißenberger, Bibiana Piqué-Leiva, Timothy H Ward, Christel Monten, Maarten Lambrecht, Marlon R. Veldwijk, Erik van Limberghen, Kiran Kancherla, Christopher J. Talbot, Barbara Noris Chiorda, Erik Briers, Sheila Shokuhi
Publikováno v:
RADIOTHERAPY AND ONCOLOGY
Radiotherapy and Oncology, 159, 241-248. Elsevier Ireland Ltd
Radiotherapy and Oncology, 159, 241-248. Elsevier Ireland Ltd
AIM: To identify the effect of single nucleotide polymorphism (SNP) interactions on the risk of toxicity following radiotherapy (RT) for prostate cancer (PCa) and propose a new method for polygenic risk score incorporating SNP-SNP interactions (PRSi)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41a7b893793cb9be0c1758ad6b546648
https://lirias.kuleuven.be/handle/20.500.12942/691375
https://lirias.kuleuven.be/handle/20.500.12942/691375
Autor:
Ludy C.H.W. Lutgens, Iva Halilaj, Y. Van Wijk, Sean Walsh, E. Van Limbergen, Ben G. L. Vanneste, Philippe Lambin
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2019 (2019)
BioMed Research International, Vol 2019 (2019)
Background. A multifactorial decision support system (mDSS) is a tool designed to improve the clinical decision-making process, while using clinical inputs for an individual patient to generate case-specific advice. The study provides an overview of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5054b5895bbd0208c0045e66c5a17c94
https://doi.org/10.1155/2019/4961768
https://doi.org/10.1155/2019/4961768
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 14, Iss, Pp 17-24 (2019)
Clinical and Translational Radiation Oncology 14(2019), 17-24
Clinical and Translational Radiation Oncology, 14, 17-24. Elsevier Ireland Ltd
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology 14(2019), 17-24
Clinical and Translational Radiation Oncology, 14, 17-24. Elsevier Ireland Ltd
Clinical and Translational Radiation Oncology
Highlights • Implantable rectum spacers (IRS) separate the ano-rectal wall (ARW) from the prostate. • Dose-surface maps (DSMs) are a tool to take spatio-dosimetric info into account. • Spatio-dosimetric differences in ARW DSMs exist comparing I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::025e5372c04dc9835b48ba5a23031bee
http://www.sciencedirect.com/science/article/pii/S240563081830082X
http://www.sciencedirect.com/science/article/pii/S240563081830082X